AgForce Enables Antigen-conditioned Generative Antibody Design

2026-05-23 · Source: cs.LG updates on arXiv.org · Field: Science & Research — Life Sciences & Biology, Health & Medical Research, Mathematics & Computational Sciences · Depth: Expert, long

Summary

AgForce, a novel encoder-decoder architecture, enables antigen-conditioned generative antibody design by addressing critical limitations in existing methods. Baseline models often ignore antigen input, leading to "antigen blindness," "vocabulary collapse" (reducing predicted amino acids to 3-5 per position), and a "cross-entropy ceiling" that prevents antigen-specific predictions. AgForce utilizes an E(3) graph neural network (EGNN) encoder and specialized decoders incorporating framework dropout, gated bottlenecks, hyperbolic cross attention, a Mixture Density Network (MDN) sequence head with Potts-like pairwise coupling, and annealed Multiple Choice Learning (aMCL). An antigen cycle consistency head further routes gradients to enforce antigen identity. On the Chimera-Bench benchmark, AgForce achieves superior binding quality and sequence recovery simultaneously, improving amino acid recovery by 8% over the strongest sequence baseline and nearly doubling the effective vocabulary of GNN methods.

Key takeaway

For AI Scientists developing generative models for therapeutic antibody engineering, you should re-evaluate standard cross-entropy loss and conditioning mechanisms. Your models may be antigen-blind and suffer from vocabulary collapse, limiting design specificity and diversity. Consider integrating architectural elements like framework dropout, Mixture Density Networks with annealed Multiple Choice Learning, and antigen consistency losses to enforce genuine antigen conditioning and expand predicted amino acid vocabularies, as demonstrated by AgForce's performance improvements.

Key insights

Existing antibody design models fail to condition on antigen, suffering from antigen blindness and vocabulary collapse due to cross-entropy loss.

Principles

• Antigen conditioning requires specific architectural interventions.
• Standard cross-entropy loss limits sequence diversity.
• Hyperbolic geometry improves binding quality.

Method

AgForce employs an EGNN encoder, MDN-Potts sequence head with aMCL, framework dropout, and an antigen consistency loss to overcome antigen blindness and vocabulary collapse in antibody design.

In practice

• Implement framework dropout to prevent antibody shortcuts.
• Use MDN-Potts head for diverse amino acid predictions.

Topics

• Antibody Design
• Generative Models
• Graph Neural Networks
• Antigen Conditioning
• Mixture Density Networks
• Therapeutic Engineering

Code references

• mansoor181/ag-force

Best for: AI Scientist, Research Scientist, Machine Learning Engineer

Related on AIssential

• DualGPT-AB: a dual-stage generative optimization framework for therapeutic antibody design — DualGPT-AB optimizes therapeutic antibody design by combining conditional GPT with reinforcement learning for multi-property sequence generation.
• ConTact: Contact-First Antibody CDR Design via Explicit Interface Reasoning — Explicitly predicting antigen contacts before sequence design significantly improves antibody CDR design performance.
• AWS and Hopkins Engineering announce groundbreaking database for AI/ML antibody design — A new diverse, experimentally validated dataset enables rigorous benchmarking of AI models for antibody developability.
• An Evolutionary Approach for Designing Stable and Highly Expressible Low-Immunogenicity Therapeutic mRNA Sequences — The BERT-GA framework optimizes therapeutic mRNA sequences for balanced translation efficiency, structural stability, and low immunogenicity.
• Scaling antibody language models improves structure aware representation for antibody engineering — Scaling antibody language models with advanced tokenization improves structure-aware representation for engineering.
• Generalizable mutation-effect prediction across adaptive immune recognition via unified multimodal framework — UniAIR unifies multimodal data and structural information to predict immune mutation effects with high generalizability.

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by cs.LG updates on arXiv.org.